India and WHO Partner to Globally Mainstream Ayush Through Landmark Agreement

Highlighting the importance of this partnership during his Mann Ki Baat address, Prime Minister expressed his optimism that this initiative will facilitate the scientific and widespread reach of Ayush systems across the globe.

This development is expected to bring about several key benefits:

  1. Transparent billing and fair pricing for Ayush services.
  2. Smoother integration of Ayush treatments into health insurance coverage.
  3. Enhanced hospital management, clinical documentation, and health research related to Ayush.
  4. Most importantly, greater global accessibility to Ayush interventions.

This partnership aligns with India’s long-term vision of integrating its rich heritage of traditional wisdom into the mainstream global healthcare system, backed by scientific classification and international standards.

Welcoming the agreement, WHO Director-General shared on X (formerly Twitter): “Pleased to sign an agreement for a $3 million contribution from #India to @WHO’s work on traditional medicine and the International Classification of Health Interventions, with @moAyush Secretary Vaidya Rajesh Kotecha. We welcome 🇮🇳’s continued commitment to #HealthForAll.”

The combined impact of ICD-11 for diseases and the new ICHI module for interventions is poised to ensure that Ayush becomes an integral, evidence-based, and policy-recognized component of global healthcare systems. This collaboration is viewed as a transformative step towards providing affordable, accessible, and trusted healthcare solutions through India’s traditional medical knowledge.

RECENT UPDATES